Please find attached a set of questions relating to venous thromboembolism in cancer patients.

Venous thromboembolism (VTE) in cancer patients

Part 1: Incidence
Question 1: How many patients has your Trust treated for cancer (of all types) in each of the past four years?
Question 2: Of the patients treated for cancer, how many also had a diagnosis of venous thromboembolism (VTE) {VTE is defined by the following ICD 10 codes: I80.0-I80.3, I80.8-I80.9, I82.9, O22.2 – O22.3, O87.0 – O87.1, I26.0, and I26.9} in each of the past four years?
Question 3: Of the patients treated for cancer who also had a diagnosis of VTE in each of the past four years, how many:
Were receiving chemotherapy?
Had metastatic disease?
Had localised disease?
Were treated for brain cancer?
Were treated for lung cancer?
Were treated for uterine cancer?
Were treated for bladder cancer?
Were treated for pancreatic cancer?
Were treated for stomach cancer?
Were treated for kidney cancer?

Part 2: Mortality
Question 4: In how many patient deaths within your Trust was cancer (of any type) listed as the primary cause of death in each of the past four years:
Question 5: Of the patients who died within your Trust, in how many was VTE as well as cancer listed as a cause of death in each of the past four years:
Question 6: Of the patients who died in your Trust who had both VTE and cancer listed as a cause of death, how many:
Were receiving chemotherapy?
Were treated for brain cancer?
Were treated for lung cancer?
Were treated for uterine cancer?
Were treated for bladder cancer?
Were treated for pancreatic cancer?
Were treated for stomach cancer?
Were treated for kidney cancer?

Part 3: Advice given to patients
Question 7: Are patients who receive chemotherapy provided with written and verbal information about the risk of developing VTE during chemotherapy? Is this information provided to chemotherapy inpatients only, chemotherapy outpatients only, or both in and outpatients?
Question 8: Are patients who receive chemotherapy provided with written and verbal information which outlines the symptoms suggestive of VTE? Is this information provided to chemotherapy inpatients only, chemotherapy outpatients only, or both in and outpatients?
Question 9: Are patients who receive chemotherapy provided with written and verbal information regarding what action they should take if they suspect a Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE)? Is this information provided to chemotherapy inpatients only, chemotherapy outpatients only, or both in and outpatients?
Question 10: Does your Trust have a policy or pathway for the management of suspected VTE in patients receiving chemotherapy?

Download response Venous Thromboembolism in cancer patients. 241016